3-(Cyanomethyl)Pyridine | CAS:6443-85-2

We serve 3-(Cyanomethyl)Pyridine CAS:6443-85-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-(Cyanomethyl)Pyridine

Chemical Name:3-(Cyanomethyl)Pyridine
CAS.NO:6443-85-2
Synonyms:3-(Cyanomethyl)Pyridine
2-pyridin-3-ylacetonitrile
2-(Pyridin-3-yl)acetonitrile
Pyridine-3-acetonitrile
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 275.4±0.0 °C at 760 mmHg
Molecular Formula C7H6N2
Molecular Weight 118.136
Flash Point 98.3±0.0 °C
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.533
 
Specification:
Appearance:Colorless liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Pyrifenox(CAS:88283-41-4).



Contact us for information like 3-(Cyanomethyl)Pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyridine-3-acetonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyridine-3-acetonitrile Use and application,Pyridine-3-acetonitrile technical grade,usp/ep/jp grade.


Related News: Could a traditional Chinese medicine help fight the Wuhan coronavirus, or is one of the country’s most influential state media outlets promoting pseudoscience and false hope?methyl 2-ethoxy-1H-benzimidazole-4-carboxylate manufacturer Could a traditional Chinese medicine help fight the Wuhan coronavirus, or is one of the country’s most influential state media outlets promoting pseudoscience and false hope?1-(Cyclopropylcarbonyl)piperazine hydrochloride supplier Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.Vitamin A palmitate vendor Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.But several border points remain open, and many medical workers fear that Hong Kong’s well-regarded health care system will be overwhelmed.